From February 6, 2024 to March 31, 2024, the company has repurchased 1,796,900 shares, representing 0.29% for CNY 22.86 million. With this, the company has completed the repurchase of 1,796,900 shares, representing 0.29% for CNY 22.86 million under the buyback announced on February 6, 2024.
Maccura Biotechnology Co.Ltd
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.93 CNY | +1.57% | +8.47% | -14.20% |
Apr. 25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
Apr. 24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.20% | 1.09B | |
+1.69% | 12.95B | |
-7.57% | 7.84B | |
+3.22% | 5.5B | |
+0.93% | 4.61B | |
+8.48% | 4.61B | |
+9.21% | 2.66B | |
-13.87% | 2.08B | |
-11.63% | 1.72B | |
+3.45% | 1.79B |
- Stock Market
- Equities
- 300463 Stock
- News Maccura Biotechnology Co.Ltd
- Tranche Update on Maccura Biotechnology Co.Ltd's Equity Buyback Plan announced on February 6, 2024.